Skip to main content

MEDIASTINAL SEMINOMA

Tracking # 20-1057910

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

MEDIASTINAL SEMINOMA IS A MALIGNANT GERM CELL TUMOR IN THE MEDIASTINUM. THE TUMOR USUALLY OCCURS IN THE ANTERIOR-SUPERIOR MEDIASTINUM IN MALES AGED 20-40 YEARS OLD. THE FIRST-LINE TREATMENT IS WITH CISPLATIN BASED CHEMOTHERAPY. TO AVOID THE HIGH MORBIDITY AND MORTALITY ASSOCIATED WITH THIS CONDITION, IT MUST BE PROMPTLY DIAGNOSED AND TREATED BY A MULTIDISCIPLINARY TEAM CONSISTING OF MEDICAL ONCOLOGISTS, RADIATION ONCOLOGISTS, AND THORACIC SURGEONS. WHEN TREATMENT IS STARTED EARLY SURVIVAL RATES ARE > 90% 5 YEAR SURVIVAL.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I